SMSRF increases research commitment
March 17, 2015 5:11 am Leave your thoughtsSmith-Magenis Syndrome Research Foundation ups research commitment Houston, TX – Mar 4, 2015 A little more than a year after announcing the dedication... Read More
Smith-Magenis Syndrome Research Foundation ups research commitment Houston, TX – Mar 4, 2015 A little more than a year after announcing the dedication... Read More
Retinoic acid induced-1 (RAI1) is an important yet understudied histone code reader that when mutated in humans results in Smith–Magenis syndrome (SMS), a neurobehavioral disorder accompanied by signature craniofacial abnormalities.
Individuals with autism spectrum disorders (ASD) who have an identifiable single-gene neurodevelopmental disorder (NDD), such as fragile X syndrome (FXS, FMR1), Smith–Magenis syndrome (SMS, RAI1), or 2q23.1 deletion syndrome (del 2q23.1, MBD5) share phenotypic features, including a high prevalence of sleep disturbance.
A new article detailing the effect of RAI1 and obesity in mice.
We are honored to announce a partnership with “Pas a Pas avec Alexia” in France. This is the first international... Read More
A Video from the Longman Family of Florida and how SMS impacts their lives.